UPDATE 1-Argos HIV immunotherapy misses main goal in study

Jan 9 (Reuters) - Argos Therapeutics Inc said its experimental immunotherapy was unsuccessful in treating HIV-infected patients, raising doubts about its technology platform and sending its stock...